These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 15321909)

  • 1. Balancing benefits and harms in health care: GPs need to be informed about drugs prescribed to their patients elsewhere.
    Randev P
    BMJ; 2004 Aug; 329(7463):457; discussion 458-9. PubMed ID: 15321909
    [No Abstract]   [Full Text] [Related]  

  • 2. Discrepancies in reported drug use in geriatric outpatients: relevance to adverse events and drug-drug interactions.
    Tulner LR; Kuper IM; Frankfort SV; van Campen JP; Koks CH; Brandjes DP; Beijnen JH
    Am J Geriatr Pharmacother; 2009 Apr; 7(2):93-104. PubMed ID: 19447362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The perils of prescribing.
    Parsons J
    Aust Fam Physician; 2002 Feb; 31(2):119. PubMed ID: 11917818
    [No Abstract]   [Full Text] [Related]  

  • 4. Consultations owing to adverse drug reactions in a single practice.
    Millar JS
    Br J Gen Pract; 2001 Feb; 51(463):130-1. PubMed ID: 11217627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse drug events in the elderly population admitted to a tertiary care hospital.
    Azad N; Tierney M; Victor G; Kumar P
    J Healthc Manag; 2002; 47(5):295-305; discussion 305-6. PubMed ID: 12325252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Problems of polypharmacy.
    Shakib S
    Aust Fam Physician; 2002 Feb; 31(2):125-8. PubMed ID: 11917821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Important that physicians perform quality assurance of drug treatment of elderly].
    Asberg KH
    Lakartidningen; 2007 Jan 10-16; 104(1-2):40-3. PubMed ID: 17323740
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevalence and predictors of polypharmacy among older primary care patients in Germany.
    Junius-Walker U; Theile G; Hummers-Pradier E
    Fam Pract; 2007 Feb; 24(1):14-9. PubMed ID: 17164234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Keeping your patient with heart failure safe: a review of potentially dangerous medications.
    Amabile CM; Spencer AP
    Arch Intern Med; 2004 Apr; 164(7):709-20. PubMed ID: 15078640
    [No Abstract]   [Full Text] [Related]  

  • 10. Balancing benefits and harms in health care: technology to collect and share information about harms already exists.
    Cervi PL
    BMJ; 2004 Aug; 329(7463):457; discussion 458-9. PubMed ID: 15321908
    [No Abstract]   [Full Text] [Related]  

  • 11. Collecting and sharing information about harms.
    Pirmohamed M; Darbyshire J
    BMJ; 2004 Jul; 329(7456):6-7. PubMed ID: 15231590
    [No Abstract]   [Full Text] [Related]  

  • 12. Adverse drug reactions--no farewell to harms.
    Aronson JK
    Br J Clin Pharmacol; 2007 Feb; 63(2):131-5. PubMed ID: 17274787
    [No Abstract]   [Full Text] [Related]  

  • 13. [The Beers List as an aid to prevent adverse drug reactions in elderly patients].
    Vingerhoets RW; van Marum RJ; Jansen PA;
    Ned Tijdschr Geneeskd; 2005 Sep; 149(38):2099-103. PubMed ID: 16201599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adverse events and adverse reactions associated with drugs--important actual spontaneous reporting of the drug event].
    Homma M
    Ryumachi; 1992 Oct; 32(5):429-31. PubMed ID: 1440077
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug adverse effects in the elderly hospitalized with acute pathologies].
    Beltrami GC; Menegolli GP; Corrà L; Weber U; Longobardi A; Albiero A; Conati GF; Grezzana M; Vecchiato D; Fusi F; Grezzana LG
    Clin Ter; 2000; 151(1):19-23. PubMed ID: 10822877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse drug reaction reporting--2000: Part 1.
    Sutcliffe H
    CMAJ; 2001 Apr; 164(7):1038, 1042. PubMed ID: 11314437
    [No Abstract]   [Full Text] [Related]  

  • 17. [Monotherapy and combined therapy for ischemic heart disease and hypertension by general practitioners].
    Ruszczyńska E; Czarnecki A
    Przegl Lek; 1994; 51(12):505-9. PubMed ID: 7746885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy at the end-of-life.
    O'Mahony D; O'Connor MN
    Age Ageing; 2011 Jul; 40(4):419-22. PubMed ID: 21622981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming problems with polypharmacy and drug misuse in the elderly.
    Montamat SC; Cusack B
    Clin Geriatr Med; 1992 Feb; 8(1):143-58. PubMed ID: 1576572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Need for monitoring adverse drug reactions.
    Nerurkar RP; Nadkar MY; Bichile SK
    J Assoc Physicians India; 1998 Aug; 46(8):673-4. PubMed ID: 11229269
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.